CompletedPhase 4ketamine
Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy
Sponsored by University of Manitoba
NCT ID
NCT02425202
Target Enrollment
36 participants
Start Date
2014-12
Est. Completion
2018-05-03
About This Study
The study will evaluate the post-operative morphine-sparing effect, pain reduction, and side effects of a continuous ketamine infusion after tonsillectomy in pediatric patients.
Conditions Studied
Interventions
- •Ketamine
- •Saline infusion
Eligibility
Age:1 Year - 17 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria: * Patients requiring tonsillectomy for diagnosis of sleep disordered breathing/obstructive sleep apnea that will be admitted for overnight cardiorespiratory monitoring, based on positive polysomnography test, positive nocturnal home oximetry, or strong signs/symptoms of OSAS Exclusion Criteria: * Patients with significant developmental delay, abnormal airway anatomy, significant co-morbidities such as cardiac disorders, respiratory disorders, neurological disorders, anad renal disorders. * Previous reaction to study medications. * Postoperative bleeding within the first 24 hours * Refusal to be involved in the study..
Study Locations (1)
Health Sciences Center
Winnipeg, Manitoba, Canada